当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 现金流量表

瑞康医药

(002589)

  

流通市值:41.65亿  总市值:45.89亿
流通股本:13.66亿   总股本:15.05亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,928,977,071.761,858,405,712.598,610,726,176.26,528,405,363.88
  收到的税费返还--384,878.5120,780.92
  收到其他与经营活动有关的现金126,836,780.0298,551,068.16983,787,571.15124,297,564.74
  经营活动现金流入小计4,055,813,851.781,956,956,780.759,594,898,625.866,652,723,709.54
  购买商品、接受劳务支付的现金3,556,767,619.561,704,840,986.567,970,723,176.375,993,711,287.05
  支付给职工以及为职工支付的现金142,824,353.8869,234,157.18310,500,127.75215,025,230.78
  支付的各项税费70,126,414.2537,036,383.99166,238,142.31116,278,004.58
  支付其他与经营活动有关的现金218,209,365.55102,819,104.26986,992,299.93316,279,516.16
  经营活动现金流出小计3,987,927,753.241,913,930,631.999,434,453,746.366,641,294,038.57
  经营活动产生的现金流量净额67,886,098.5443,026,148.76160,444,879.511,429,670.97
二、投资活动产生的现金流量:
  收回投资收到的现金--174,394,283.83174,381,187.15
  取得投资收益收到的现金8,806,344.084,310,762.6196,321.468,631,597.44
  处置固定资产、无形资产和其他长期资产收回的现金净额15,310,562.866,985,050.33750,306.9835,229,411.55
  处置子公司及其他营业单位收到的现金净额37,377,573.4813,743,747.3226,272,268.5151,416,441.5
  收到的其他与投资活动有关的现金170,000,000-659,935,021.6499,000,000
  投资活动现金流入小计231,494,480.4225,039,560.231,061,548,202.41468,658,637.64
  购建固定资产、无形资产和其他长期资产支付的现金77,126,743.9624,396,079.85111,528,429.1349,367,742.41
  投资支付的现金--83,950,60053,950,600
  支付其他与投资活动有关的现金290,000,000-662,091,793.0499,000,000
  投资活动现金流出小计367,126,743.9624,396,079.85857,570,822.17202,318,342.41
  投资活动产生的现金流量净额-135,632,263.54643,480.38203,977,380.24266,340,295.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金20,000,000-0-
  其中:子公司吸收少数股东投资收到的现金20,000,000---
  取得借款收到的现金1,788,053,603.211,371,148,453.622,712,537,743.54,109,926,841.25
  收到其他与筹资活动有关的现金7,320,684,452.834,065,429,137.2118,646,150,525.4710,863,998,016.17
  筹资活动现金流入小计9,128,738,056.045,436,577,590.8321,358,688,268.9714,973,924,857.42
  偿还债务支付的现金2,289,329,415.891,793,511,022.522,961,022,602.214,439,190,815.8
  分配股利、利润或偿付利息支付的现金119,097,382.5173,506,658.48198,706,434.71167,140,273.68
  其中:子公司支付给少数股东的股利、利润--0-
  支付其他与筹资活动有关的现金6,574,377,996.813,329,910,526.0418,345,434,035.9910,504,460,223.71
  筹资活动现金流出小计8,982,804,795.215,196,928,207.0421,505,163,072.9115,110,791,313.19
  筹资活动产生的现金流量净额145,933,260.83239,649,383.79-146,474,803.94-136,866,455.77
五、现金及现金等价物净增加额78,187,095.83283,319,012.93217,947,455.8140,903,510.43
  加:期初现金及现金等价物余额690,322,926.07689,889,358.53471,941,902.73471,941,902.73
  期末现金及现金等价物余额768,510,021.9973,208,371.46689,889,358.53612,845,413.16
补充资料:
  净利润30,605,041.88-41,017,810.26-
  资产减值准备-53,240,838.15-69,614,649.77-
  固定资产和投资性房地产折旧58,460,173.46-123,253,688.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧58,460,173.46-123,253,688.89-
  无形资产摊销28,045,236.08-72,707,914.38-
  长期待摊费用摊销9,269,254.63-16,908,760.95-
  处置固定资产、无形资产和其他长期资产的损失-173,176.52--18,938,795.04-
  固定资产报废损失-1,486,722.43-613,628.5-
  公允价值变动损失890,896.12--30,647,078.86-
  财务费用117,884,999.14-193,866,434.08-
  投资损失-12,404,896.21--96,213,121.33-
  递延所得税-45,300,699.75--684,134.14-
  其中:递延所得税资产减少-42,678,969.24--1,705,017.97-
    递延所得税负债增加-2,621,730.51-1,020,883.83-
  存货的减少-77,583,304.12-385,037,580.88-
  经营性应收项目的减少-98,682,537.85-61,010,422.2-
  经营性应付项目的增加110,657,557.8--660,284,218.26-
  现金的期末余额768,510,021.9-689,889,358.53-
  减:现金的期初余额690,322,926.07-471,941,902.73-
  现金及现金等价物的净增加额78,187,095.83-217,947,455.8-
公告日期2025-08-262025-04-302025-04-242024-10-31
审计意见(境内)标准无保留意见
TOP↑